Sponsor:
Janssen Research & Development, LLC
Code:
NCT06667076
Conditions
Carcinoma, Non-Small-Cell Lung
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Amivantamab
Lazertinib
Chemotherapy: Pemetrexed
Chemotherapy: Carboplatin
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations